Early research (Phase 1)Study completedNCT03611946
What this trial is testing
Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults
Who this might be right for
Zika Virus
National Institute of Allergy and Infectious Diseases (NIAID) 56